LIPT1 and hepatocellular carcinoma: developed a prognostic risk model utilizing CRGs (glycine cleavage system protein H, lipoyltransferase 1, and cyclin dependent kinase inhibitor 2A), revealing that downregulation of lipoyltransferase 1 can impede the proliferation and invasion of HCC cells.